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A B S T R A C T
In interventional electrophysiology, catheter-based radiofrequency (RF) ablation procedures restore cardiac
heart rhythm by interrupting aberrant conduction paths. Real-time feedback on lesion formation and post-
treatment lesion assessment could overcome procedural challenges related to ablation of underlying structures
and lesion gaps. This study aims to evaluate real-time visualization of lesion progression and continuity during
intra-atrial ablation with photoacoustic (PA) imaging, using clinically deployable technology. A PA-enabled RF
ablation catheter was used to ablate and illuminate porcine left atrium, both excised and intact in a passive
beating heart ex-vivo, for photoacoustic signal generation. PA signals were received with an intracardiac
echography catheter. Using the ratio of PA images acquired with excitation wavelengths of 790 nm and 930 nm,
ablation lesions were successfully imaged through circulating saline and/or blood, and lesion gaps were iden-
tiﬁed in real-time. PA-based assessment of RF-ablation lesions was successful in a realistic preclinical model of
atrial intervention.
1. Introduction
Atrial ﬁbrillation (AF) is the most common and most persistent ar-
rhythmia with high morbidity and mortality rates [1]. AF is associated
with an increased probability of stroke, heart failure and hospitaliza-
tion. Radiofrequency (RF) ablation is one of the potential curative
treatments of AF. In RF ablation procedures, a catheter is positioned in
the left atrium to isolate the pulmonary veins (PV) and create additional
lesions in areas with fractionated potentials as needed, guided by
electroanatomical maps. During these long-lasting procedures, tissue is
ablated (rendered nonconductive) with RF energy to isolate the PV,
while being cautious not to ablate underlying structures such as the
esophagus. The procedural success rate of AF ablation is approximately
60–80 % when accounting for redo ablations [2–4]. This low success
rate is mostly attributed to PV reconnection or the presence of an ex-
tensive arrhythmogenic substrate outside the PV [5–7]. Gaps in the
lesion trace as well as the inability to discern edema from tissue ne-
crosis may result in arrhythmia recurrence [5,8]. Catheter positions,
contact force and local electrograms can be measured and visualized,
but treatment delivery and lesion extent are estimated based on a
combination of thermodynamic- and biophysics-based models and
heuristics for the diﬀerent atrial sites [9,10] without regard for anato-
mical variations among patients. Development of a tool that provides
direct lesion visualization, assessment and monitoring could potentially
increase the success rate of this procedure [5,11].
Thus far, Magnetic Resonance Imaging (MRI) and ultrasound elas-
tography were the only two imaging modalities shown to assess RF
ablation lesions in humans. However, both face challenges in mon-
itoring lesion formation during RF energy delivery due to device
compatibility, temporal resolution and motion artefacts caused by an
asynchrony of acquisitions in an irregular heart rhythm [12,13]. Ul-
trasound imaging studies [14,15] showed promising results in mon-
itoring RF ablation lesions in animal models but the small ﬁeld of view
of the imaging catheters that were used limits the assessment of the
lesion as a whole. In addition, the image features characterizing abla-
tion lesions were neither consistent between studies [16] nor persistent
in ex-vivo evaluation setups [17]; a necessary feature for post-ablation
lesion continuity assessment. Optical methods, such as near infrared
spectroscopy (NIRS), or polarization sensitive-/ optical coherence to-
mography (PS-/OCT), were also considered for the problem of lesion
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monitoring [18–21]. However, NIRS imaging contrast relies heavily on
optical modelling, which is sensitive to device and tissue geometry.
NIRS is therefore likely to be aﬀected by variations in tissue thickness
and by the sampling catheter orientation in the highly mobile en-
vironment of a beating heart. Spectroscopic approaches are though
currently being researched towards solving this challenge [22,23]. An
OCT based solution to monitoring ablation lesion formation in real-time
looks very promising, considering it provides the highest resolution of
all considered modalities. PS-/OCT-enabled ablation catheter proto-
types were demonstrated [20,21] to simultaneously ablate and image
lesion extent using both tissue birefringence signal as well as tissue
scattering changes. However, OCT methods have yet to be demon-
strated on atrial tissue and are more limited than photoacoustic
methods in imaging depth.To this day, no imaging technology provides
real-time, complete and/or reliable means for AF treatment monitoring
and evaluation, either lacking feedback during energy delivery, or ca-
pacity to assess lesion continuity and quality post energy delivery.
Photoacoustic (PA) imaging contrast relies on tissue optical ab-
sorption. Photoacoustic imaging requires an illumination source and an
ultrasound transducer to detect acoustic waves generated by light ab-
sorption. Ablated tissue is optically diﬀerent from untreated tissue.
White-light video endoscopy, used to guide laser-ablation procedures,
conﬁrms that this contrast also exists in vivo. Previous studies showed
that PA imaging can monitor lesion progression during RF delivery in
ex-vivo porcine myocardium [24–26]. We have previously character-
ized ablated and non-ablated porcine atrial tissue and found PA spec-
troscopic diﬀerences between the two types, likely related to changes in
hemichrome, methmyoglobin and protein denaturalization contents.
Spectroscopic based imaging was reliably reduced to a dual wavelength
PA imaging scheme, which was shown to robustly assess lesions in
porcine atrial tissue with 97 % diagnostic accuracy [25]. From an in-
strumentation perspective, ablation catheters combining the delivery of
both radiofrequency current for ablation and pulsed laser light for si-
multaneous photoacoustic imaging were previously demonstrated to
enable ablation lesion monitoring [27,28]. We take a next step in the
clinical translation of this concept with intracardiac ablation imaging.
We also use an actual ICE catheter for signal collection, introducing its
characteristic small aperture and modest sensitivity.
This study aimed to assess lesion progression and continuity during
intra-atrial ablation with photoacoustic imaging in real-time, using
technology that is compatible with clinical deployment. Porcine atrial
tissues ex vivo were used, both excised and in a beating heart setup, in
saline and in blood. These experiments demonstrate the potential of PA
imaging feedback of RF-induced tissue changes for energy delivery ti-
tration as well as for evaluation of lesion transmurality and identiﬁ-
cation of lesion gaps, which are important parameters for successful,
permanent and safe ectopic source isolation.
2. Methods
2.1. Imaging system
The imaging system uses technology that is commonly found in
interventional electrophysiology clinics. An ICE catheter (3.1 mm outer
diameter, 2.45mm at the tip, 60/64 connected channels, 6.5 MHz,
ViewFlex, St Jude Medical, Saint Paul, Minnesota) was connected to a
research ultrasound system (Verasonics Vantage256, Kirkland,
Washington) for signal digitization, processing and display. A medical
RF generator (EPT1000XP APM system, Boston Scientiﬁc,
Marlborough, Massachusetts) delivered energy to an ablation catheter
(Blazer, EPT9620K2, Boston Scientiﬁc, Marlborough, Massachusetts),
modiﬁed to deliver laser light (RFPA catheter). The RFPA catheter used
for most of the experiments was of 2.4 mm (7 F) outer diameter and
ﬁtted one 400 μm core diameter, NA=0.39 multi-mode optical ﬁber
(FT400EMT, Thorlabs, Newton, NJ) through the ﬂushing channel [27].
An alternative design, used in the blood-ﬁlled heart, comprised three
200 μm ﬁbers (FP200ERT, Thorlabs, Newton, NJ) placed around the
ablation tip; the catheter outer diameter was of 2.4mm ending in an
ablation tip electrode of 1.8mm (Fig. 1b2). PA imaging performance of
both catheters was previously found to be similar [27]. The RFPA ca-
theter was also connected to a tunable, 100 Hz pulsed laser
(660−2400 nm, 6 ns pulse width, Spitlight EVO-OPO, Innolas, Krail-
ling, Germany). This way, the RFPA catheter can deliver excitation light
directly at the ablation site, enabling simultaneous ablation and PA
imaging of cardiac tissue.
2.2. Image acquisition and processing
The imaging sequence consisted of ﬁve ultrasound pulse-echo (di-
verging wave) acquisitions, followed by N paired PA acquisitions at 790
and 930 nm (Fig. 1a). Signal digitization, ﬁltering and image re-
construction was performed using the Verasonics software. Ultrasound
time gain compensation (TGC) was adjusted as needed during the
imaging based on real-time feedback, while the PA TGC was ﬁxed to a
maximum and not controllable during the acquisition. PA images were
averaged (N times) and corrected for laser ﬂuence ﬂuctuations. Single
Fig. 1. Methodology. (a) An imaging frame consists of 5 ul-
trasound acquisitions and N photoacoustic acquisitions com-
posed of acquisitions at λ1=790 nm and λ2=930 nm. The
shaded area represents the signal acquisition time. The setup
comprises an ultrasound research system, a tunable laser and
an ablation system. (b) Excised porcine tissue is imaged in
transmission mode photoacoustic with the ablation catheter
on the endocardium side. Insert (1) is a photograph of the
single ﬁber catheter RFPA catheter prototype and insert (2) of
the three-ﬁber RFPA catheter. (c) Photo of the beating heart
setup with the ablation indiﬀerent electrodes positioned under
the heart and the circulating ﬂuid is blood. Real-time US/PA
monitoring and endoscopy were available. The bottom of the
ﬁgure shows snapshots of both the endoscope monitoring
screen looking down at the mitral valve (bottom right) and of
the intracardiac echography monitoring screen (bottom left).
Intracardiac echo catheter: ICE-C, PA-enabled RF ablation
catheter: RFPA, Mitral valve: MV.
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wavelength images are labeled by their excitation wavelength λ (Iλ). N
is minimized and optimized to achieve adequate signal-to-noise ratio
(SNR), which depends on the laser pulse energy and RFPA catheter
alignment with the ICE catheter imaging plane. The relative excitation
pulse energy was inferred from the signal originating at the catheter tip.
Dual wavelength PA imaging (2λPA), deﬁned as the ratio of I790 to
I930, can identify and delineate ablation lesions [25]. To monitor lesion
progression and compensate for the eﬀects of cardiac motion and laser
optical output variability, 2λPA images were further processed. Since
the 2λPA image SNR depends on the initial image quality, I790 and I930
frames of suﬃcient SNR were smoothed along the frames using a 1st
order Savitzky–Golay ﬁlter of length equal to the number of frames in
one heartbeat. For the static experiments, we set the ﬁlter length to 5.
Moreover, 2λPA is a ratio thresholding method, thus, to remove any
random additive noise we subtract the mean (μ represents the mean
operation) from each image before taking the ratio:
=
−
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Any random spurious noise will be enhanced by the division op-
eration, which is suppressed by a moving average ﬁlter based on the
previous 3 frames: ∑− Si
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1
3 2 to compute the ﬁnal 2λPA image. 2λPA
imaging, at the selected wavelengths, theoretically ensures that non-
ablated tissue of varying tissue oxygenation levels – as well as blood –
display <S 1R while lesion areas are characterized by >S 1R [25].
2λPA imaging also ensures that signal increase solely reﬂects tissue
changes, not temperature variations [29].
We measured that 1mJ of optical input can penetrate up to 8mm of
porcine atrial tissue at the chosen wavelengths. However, with laser
pulse-to-pulse energy decrements, penetration depth can be reduced.
2λPA imaging depth cannot exceed the smallest probed depth by any of
the Iλ images used. To only display information with suﬃcient ﬁdelity,
the ﬁnal 2λPA image is masked based on the minimum SNR of either
PA image.
Finally, by compounding 2λPA images for diﬀerent RFPA catheter
positions, registered using echo information, continuity of lesions post
ablation is evaluated. Criteria for frame selection are (1) SNR≥ 10 dB
and (2) high correlation between the frames on ultrasound. Final,
compounded images are binary images composed of multiple 2λPA
frames processed such that pixels above a threshold of 1 are set to red
and the rest to NaN.
2.3. Ablation of excised cardiac tissue
Fresh (0−24 h after slaughter) porcine atrial tissue from the local
butcher was mounted with wires on a holder, and submerged in
phosphate-buﬀered saline (PBS) [25]. The ICE catheter was positioned
on the epicardial side and the RFPA catheter on the endocardial side
(Fig. 1b). Four laser pulses were averaged to form a single photo-
acoustic image (N=4), yielding a frame rate of 12.5 Hz. The average
pulse energy delivered at the catheter tip was ∼1mJ at 790 nm and
∼0.6mJ at 930 nm. The ablation system used did not have irrigation
capability. Ablation was performed in power-controlled mode (25W for
25 s), since temperature feedback was not available from the modiﬁed
catheter. Four ablation lesions were formed and imaged in real-time.
We also assessed the continuity of the lesions by moving and ﬂexing the
RFPA catheter around the lesions made, aiming to illuminate and
generate signals from the entire treated volume (as opposed to at lesion
sites only). During the manipulation, we did not move the receiving ICE
catheter. The result is thus an evaluation of the lesion continuity within
the imaging 2D plane probed by the ICE.
2.4. Ablation in a passive beating heart
A porcine heart was mounted in a circulation system (Cardiac
Biosimulator, LifeTec Group, Eindhoven, Netherlands), ﬁlled with 5
liters of ﬂuid (saline or heparinized blood). The ﬂuid ﬂowed from the
aorta and drained through an opening made in the apex of the left
ventricle (Fig. 1c); other cavities were ﬁlled through hydrostatic pres-
sure. A pulsatile pump, set to 1 Hz, created a ﬂuid ﬂow of 4.5 L/min.
This setup is a representative model for cardiac motion and is fre-
quently used in the training of catheter-based cardiac interventions
[30]. We inserted the RFPA and ICE catheters through the jointly tied
PV into the left atrium. When working in saline, the video endoscope,
positioned in the PV, visualizes the catheters and the sites where we
applied RF energy (10−30W, 35 s) (Fig. 1c). Iλ were not averaged
(N=1), enabling an eﬀective excitation frame rate of 50 Hz. Due to
memory management limitations in our ultrasound system, the saving
frame rate varied and was restricted to 6 Hz maximum.
In saline, we monitored a series of ablation lesions (without catheter
irrigation) on the mitral annulus and nearby tissue, documenting them
on video. Blood precludes the use of the video endoscope. Thus, prior to
ﬂushing the heart with heparinized blood, we positioned the catheters
under endoscopic guidance, such that the ICE catheter images capture
the RFPA catheter. In blood, we monitored the formation of one lesion
(30W, 30 s). After imaging, the heart was cut open, washed and its
inner surface evaluated for lesions. With the aid of the endoscopy vi-
deos, all lesions could be related to the imaging acquisitions. We cut
through the lesions to examine depth and extent, documenting them in
photographs.
3. Results
3.1. RF ablation monitoring in a static setup
We monitored lesion formation in a static setup with the 2λPA
imaging scheme. Fig. 2 documents the monitoring of a lesion made in
this specimen. We set timepoint t= 0 to represent the beginning of
ablation. Comparison of Iλ frames (Fig. 2b) to 2λPA (Fig. 2a) frames at
the beginning of ablation shows robustness of the latter in eliminating
signals from the catheter tip. The ﬁnal 2λPA image clearly delineates
the lesion, matching the photograph in Fig. 2d. 2λPA imaging is less
aﬀected by RF interference artefacts. These are prominent in Iλ, de-
pending on the image SNR. 2λPA monitoring of the lesion formation
depicted by Fig. 2 is included as Movie 1. Intermittent glitches of signals
occur when the RFPA catheter relocates, or when it is deforming the
tissue, as a result of N=4 frame averaging. The formed lesion seemed
superﬁcial which was conﬁrmed by cutting through the tissue at the
lesion site, Fig. 2d. A clear advantage of 2λPA imaging over single
wavelength PA (Iλ) imaging (Fig. 2) is a simple and intuitive binary
representation of the presence/absence of lesion allowing easy lesion
progression visualization.
In total, formation of four lesions was successfully monitored in this
manner, Fig. 3. Each lesion is labeled with a number. Ablation lesion
continuity is key to procedural success. Point source light delivery from
the RFPA catheter limits the imaging ﬁeld of view to the illuminated
area. To obtain an overall view of all lesions made, we moved the RFPA
catheter to illuminate all the treated region and recorded the signals.
Compounded acquisitions formed one ﬁnal image revealing lesion
continuity along the ICE imaging plane Fig. 3a). Gaps were identiﬁed
between lesions 1 and 2 and between 3 and 4, while 2 and 3 are
overlapping.
3.2. RF ablation monitoring in a beating heart ex vivo in saline
In a beating heart ﬁlled with circulating saline, we applied RF en-
ergy for various durations and power settings. We monitored the for-
mation of four ablation lesions. Fig. 4 shows a lesion being created
(using 28W for 35 s). Both the RFPA catheter and ICE catheter were
positioned around the mitral valve as shown in Fig. 4,e. Fig. 4a depicts
2λPA images before, after and during ablation and Fig. 4b their
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equivalent I790 frames. As in the static setup, 2λPA imaging enables
lesion formation visualization, while it remains challenging to distin-
guish lesions from untreated tissue sites and from the RFPA catheter tip
on Iλ images. Movie 2 documents the process of ablation, with a ﬁnal
lesion signal reﬂecting its true size (Fig. 4c). Fig. 4d is a frame from the
endoscope used to monitor and guide the procedure, illustrating the
tissue surface discoloration after removing the catheter from the abla-
tion site. A small deﬂection/crater (cyan arrows Fig. 4) at the tissue
surface appeared where the ablation was performed. This further con-
ﬁrms that ultrasound, PA and endoscopy video data all had the ablation
site in view.
Lesion continuity and gap sizing is evaluated in the beating heart
setting by serially ablating two sites in one ICE scene. After monitoring
the formation of yet another lesion, we dragged the RFPA catheter to
the closest (previously ablated) lesion site within the ICE catheter ﬁeld
of view, guided by the video endoscope. Movie 3 shows the monitoring
of the lesion formation as well as the movement of the catheter to the
closest lesion site, where the endoscope frame rate is matched to that of
our acquisition scheme. Fig. 5a,b show post-ablation 2λPA images and
their corresponding endoscopy frames, and lesions as photographed in
tissue. A compound image, based on 2λPA image pixels of SR>1,
enables lesions respective localization and allows sizing of the gap in
between (Fig. 5c). Cardiac motion required correlating ICE imaging
frames before compounding. We successfully identiﬁed ablation gaps in
the challenging setup of a beating heart with a 2D ultrasound ﬁeld of
view.
To qualitatively assess the speciﬁcity of the PA signal for ablated
tissue, we evaluated a control case of low energy delivery (10W, 35 s).
Endoscopic images showed no tissue surface discoloration suggesting
no tissue ablation occurred; this was later conﬁrmed by post-experi-
mental tissue examination. Fig. 6a documents the energy delivery
process with 2λPA imaging, conﬁrming the absence of lesion forma-
tion, also available as Movie 4. No persistent lesion-like signal is ob-
served. Incidental glitches may result from imperfect laser pulse energy
ﬂuctuation correction since N=1. Single wavelength PA (Iλ) images
(Fig. 6b), on the other hand, hardly discriminate the presence or ab-
sence of lesion. Fig. 6c,d illustrate catheter positions relating the tissue
structures observed on ultrasound.
3.3. Visualization of lesion formation in blood
Blood has a high optical absorption coeﬃcient and could potentially
interfere with PA imaging, by showing as a positive signal, or by
strongly attenuating the light reaching the tissue. We designed the
presented imaging technology for compatibility with blood by placing
the light source in contact with the tissue. We tested imaging
Fig. 2. Ablation monitoring of excised left atrium. (a) 2λPA images before, during and after ablation, available as Movie 1. The 2λPA signal is encoded as opacity of
the red overlay on the ultrasound image. (b) Corresponding I790 images. Ultrasound (US) image is in grayscale. Photoacoustic image is in red-yellow-white scale. (c)
Photograph of the setup. (d) Photograph of lesion made, dashed line delineates lesion extent. Scale bar represents 2mm. White arrows indicate ablation (RFPA-C)
catheter location.
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4
performance by changing the beating heart circulation medium to
(deoxygenated) blood and monitoring the creation of another lesion. PA
signals from tissue were successfully generated (Fig. 7b). Since both I790
and I930 displayed suﬃcient tissue SNR, we generated 2λPA images,
and established that the imaging site was initially free from lesions
(Fig. 7a, left panel). This conﬁrms that blood does not generate false-
positive lesion sites in 2λPA imaging. After the ablation, a clear signal
indicating lesion presence is observed (Fig. 7a, right panel), and is
corroborated with tissue examination (Fig. 7c). We have measured a
lesion size of 3.6× 2mm (lateral x axial) after tissue examination,
while the photoacoustic image showed a lesion size of 3.9× 3mm
(lateral x axial). Lesions are growing in 3 dimensions and thus the le-
sion sizing is highly dependent on the matching between sectioned and
imaged planes which was diﬃcult in this highly mobile experiment.
Movie 5 documents the ablation process (30W, 60 s) through blood
around the mitral valve annulus; the valve motion appears erratic due
to the low imaging frame rate. Fig. 7d illustrates catheter positions,
deduced from ICE image features. Acquisition in blood was performed
with the three-ﬁber RFPA catheter after failure of the ﬁrst prototype.
4. Discussion
4.1. Imaging system and method
Imaging of ablation lesion progression was achieved with dual-
wavelength intracardiac photoacoustics, showing robust lesion contrast
in the presence of blood and cardiac motion. Lesion formation, being a
slow process (30–60 s), does not require a high frame rate for timely
feedback. However, rapid acquisition between the two wavelengths
constituting a 2λPA imaging frame is essential to ensure minimal sen-
sitivity to motion and to guarantee that both Iλ1 and Iλ2 capture the
same lesion stage. Averaging the SR frames rather than the Iλ frames
minimizes the occurrence of imaging glitches due to motion.
The non-negligible elevational focus of the imaging system, which
varied with imaging depth, did not allow for an exact matching of
images to cross-sectional tissue photographs. In future work, we will
establish imaging resolution (e.g. minimum gap detection) and estab-
lish the PA contrast for diﬀerent tissue ablative stages; these experi-
ments require an improved lateral resolution and exact co-registration
which can be obtained with a 3D scanning stage and a focused trans-
ducer. Following these considerations, we have also chosen not to
perform a quantitative validation of lesion size comparing with his-
tology. In previous experiments, we found that NTC (Nitro Blue
Tetrazolium) stained sections provided the same information on abla-
tion lesion location and extent as visual inspection. We veriﬁed whether
lesions were continuous or not (maximum diameter) and transmural or
not (maximum depth) based on visual inspection, documented in
photographs.
2λPA images represent better the signal through depth than single
wavelength Iλ images, which are saturated by the stronger signals from
both the RFPA catheter metallic tip and tissue surface. A threshold
value of >S 1R was used to robustly diﬀerentiate between the absence
and presence of lesions in 2λPA images. Detected lesion signals were
persistent, which means they originate from tissue changes and not
from elevated temperature. Future work may establish a correlation
between gradation of ablation lesions and SR, potentially allowing
identiﬁcation of, for instance, reversible lesions, steam build-up,
edema, and charring. In the experiments performed here, occasional
hematoma-like damage to the tissue due to catheter contact force was
not identiﬁed as a lesion.
In-depth tissue illumination is key to generate 2λPA images re-
ﬂecting correct lesion extent, and reduces the sensitivity to superﬁcial
Fig. 3. Evaluation of lesion continuity. (a) Compound 2λPAI image. (b) Top view (endocardial side) of tissue; lesions 2 and 3 are continuous as visible in (a); 1 and 4
are separated from their respective adjacent lesions. Lesion 3 is inside the separate bundle structure as seen in (c). (c) Cross-section through the lesions (unfolding the
tissue disconnected lesions 2 from 3). Scale bar represents 5mm.
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(endocardium) optical properties. We fabricated two diﬀerent proto-
types of RFPA catheter. While we previously showed that these were
performing equally, [27] we did not consider the factors of maneu-
verability and catheter orientation. A three-ﬁber prototype allowed for
eﬃcient tissue illumination for a larger set of ablation catheter contact
angles than a single, centered ﬁber prototype. For instance, in Fig. 2,
visualization of the lateral extent of the lesion is dependent on the
orientation of the illumination; compound images obtained by moving
the catheter were necessary to reveal the lateral extent of the lesion
(Fig. 3). On ultrasound images, the RFPA catheter shaft echogenicity
varied with the change in relative positions of the ICE and RFPA ca-
theters due to cardiac motion. Fluctuations in both 2λPA images and Iλ
signals may partially be related to catheter orientation and position
within the ICE-C ﬁeld of view; we notice that advancing or retracting
Fig. 4. Ablation monitoring in a beating heart. (a) 2λPA images before, during and after ablation, available as Movie 2. (b) I790 equivalents. 2λPA data conﬁrm lesion
formation. (c) Photograph of lesion made. (d) Video endoscopy frame conﬁrming a lesion was made. (e) Sketch of instruments positions adapted from [31]. Round
inset: ICE-C and RFPA-C relative to the valve, oriented as in the images in (a) and (b). ICE catheter (ICE-C); PA-enabled ablation catheter (RFPA-C). Mitral valve
(MV). Cyan arrows indicate indentation formed by ablation.
Fig. 5. Lesion continuity in a beating heart. 2λPA image, corresponding endoscope frames and lesions photographs of the newly formed lesion site (a); old lesion site
(b) and the resulting composite image (c) available as Movie 3. Arrows indicate lesion sites.
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the catheter with respect to the tissue surface aﬀects the collected
signal. Eﬀects of catheter design and catheter tip contact angle and
force with tissue surface on signal generation shall thus be further
studied.
4.2. Tissue handling and translation to in-vivo scenario
The results presented here, on fresh tissues (< 8 h from sacriﬁce in
the intact hearts) partially perfused with deoxygenated blood, show
that 2λPA imaging is not aﬀected by the surrounding blood. However,
2λPA imaging is based on optical spectral contrast; live cardiac tissue
perfusion and oxygenation will diﬀer from our ex-vivo setup. Increased
perfusion in vivo could aﬀect the imaging depth and optical propaga-
tion paths due to blood scattering, but the well-characterized absorp-
tion spectra of blood and myocardium suggest that lesion contrast
should be even stronger in a highly oxygenated scenario. Nevertheless,
experimental validation is needed.
Some diﬀerences with clinical practice need to be addressed before
generalization of the presented results. First, imaging was performed on
a controlled, low heart rate, where in reality heartbeats can be fast and
erratic during AF. Imaging artefacts due to motion and catheter or-
ientation may thus be exacerbated in patients. A higher frame rate will
certainly help in imaging more variable motion. Second, since the PV
were tied together to prevent ﬂuid outﬂow, we ablated around the
mitral valve annulus. Since we did not see quantitative or qualitative
diﬀerences between lesions produced in the static setup (which in-
cluded atrial tissues near the PV) and in the beating heart, we assume
that successful lesion monitoring and assessment on the mitral valve
annulus is representative of imaging capability in other atrial locations.
Third, we used porcine hearts, which are considered a representative
model of the human heart, but our imaging results depend on detailed
tissue optics and need to be conﬁrmed on human atrial specimens.
Preliminary experiments (Supplementary Fig. 1) as well literature stu-
dies [32] show that human and porcine cardiac tissues optical signature
are similar in the wavelength range of interest. Our results are thus
likely to be generalizable to human tissue ablation.
4.3. Clinical perspective
Unlike other proposed technology candidates to monitor RF abla-
tion for AF, [13,15] 2λPA imaging allows both real-time monitoring
and depth-resolved lesion continuity assessment. Our implementation
builds on existing commercial technologies and requires minimal
modiﬁcation of current clinical routine, adding an unobtrusive layer of
feedback on lesion quality during the procedure. Integration to current
mapping systems could provide a 3D rendering of the PA-assessed le-
sion extent on the electroanatomical map. PA signals can be used to
derive a number of useful parameters for intervention guidance beyond
lesion quality: Iλ directly depends on tissue temperature; and signals
from the catheter may assist navigation in atrial 3D-ICE volumes.
Future work targets in-vivo demonstration in animal models.
Correlation of PA image characteristics to electrical lesion functionality,
as well as to complications such as steam-pops, will deﬁne image in-
terpretation for use in guidance of clinical interventions. Evaluation of
the technology in a clinical research setting should demonstrate the
practical value of PA imaging in ablative therapy of the atria. Gains in
procedure safety, speed and eﬃcacy are anticipated, but should be
tested, and will precede any studies of impact on procedural success.
Fig. 6. True negative: monitoring of low-power RF energy delivery in a beating heart. (a) 2λPA images before, during and after energy delivery. (b). I790
equivalents. The 2λPA data conﬁrm absence of lesion (Movie 4). Cyan arrows indicate the treated region. C. Sketch of instruments positions and imaging plane
(adapted from [31]) as shown in (d). ICE-C: intracardiac echography catheter (green and grey); RFPA-C: PA-enabled ablation catheter (purple and grey); MV: mitral
valve.
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5. Conclusion
Dual wavelength photoacoustics (2λPA), based on the ratio of
images acquired at 790 nm and 930 nm, can provide real-time
monitoring of intra-atrial RF ablation procedures in a blood-ﬁlled
beating heart. Videos of ablation lesion formation, and identiﬁcation of
lesion gaps were achieved, with clinically-translatable instruments,
consisting of a modiﬁed ablation catheter for illumination and ICE for
Fig. 7. Ablation monitoring in a beating heart ﬁlled with circulating blood. (a) 2λPA images at the beginning and after ablation and (b) I790 equivalents conﬁrming
presence of PA signal from tissue. (c) Photograph of the (superﬁcial) lesion. (d) Sketch of instruments positions (adapted from [31]) Oval inset: ICE-C and RFPA-C
relative to the valve, oriented as in the images in (a) and (b). (a) is available as Movie 5.
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signal detection. Using 2λPA signals from lesions could be dis-
criminated from blood and healthy tissue, and were persistent after
ablation. The presented solution has the advantage of being simple in
implementation, easy to integrate and free from heuristics, modeling or
time-consuming computations.
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